
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 4 publications
Mesothelin promotes acute myeloid leukemia progression through LYN-dependent signaling.
Journal: The Journal of biological chemistry
Published: September 04, 2025
Mesothelin: An Immunotherapeutic Target beyond Solid Tumors.
Journal: Cancers
Published: February 14, 2022
Aggressive Hematopoietic Malignancy Characterized by Biallelic Loss of SMARCB1.
Journal: JCO precision oncology
Published: September 11, 2020
Showing 1-4 of 4
Last Updated: 09/26/2026